Each shot would be completely personalized to the patient.

Wagner’s TLPO cancer vaccine has been tested in hundreds of patients with advanced forms of melanoma in Phase 2 clinical trials.

The most recent data presented at an academic conference showed nearly 95% of people given only the vaccine were still alive three years after starting treatment and 64% were still disease-free. Among the most advanced forms of melanoma, disease-free survival after three years for people with stage III disease was 60% in the vaccine-only group, compared to about 39% in the placebo group. Disease-free survival for those with stage IV disease was about 68% in the vaccine-only group, and zero in the placebo group.

The most common side effects were redness or pain at the injection site, fever and fatigue after the injection – similar to other vaccines that stimulate an immune response.

  • Szymon@lemmy.ca
    link
    fedilink
    English
    arrow-up
    0
    ·
    8 months ago

    I know it’s for scientific purpose and all, and they signed off on it, but what a bum fucking deal to get a placebo in that stage 4 group.

    • Tvkan@feddit.de
      link
      fedilink
      arrow-up
      0
      ·
      8 months ago

      In later trials, drugs aren’t compared against placebo, but a standard therapy regimen.

  • BigMacHole@lemm.ee
    link
    fedilink
    arrow-up
    0
    arrow-down
    1
    ·
    8 months ago

    But how will Hospital CEOS and Pharma CEOs make money if they Cure Cancer instead of just Treat Cancer?